[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100526884":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":11,"centralContacts":11,"locations":11,"responsibleParty":28,"collaborators":30,"id":44,"slug":11,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":11,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":11,"studyType":56,"phases":57,"briefSummary":59,"conditions":60,"keywords":62,"overallStatus":65,"whyStopped":11,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":11},{"fullName":5,"class":6},"Bochang","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Experimental group","EXPERIMENTAL",null,[13],"Device: Drug balloon dilated",{"label":15,"type":10,"description":11,"interventionNames":16},"Control group",[17],"Device: balloon dilated",[19,24],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":11},"DEVICE","Drug balloon dilated","Through the expansion after the balloon is in place,Release drugs on the surface of the balloon and improve the blood perfusion of nerve vessels to treat stenosis",[9],{"type":20,"name":25,"description":26,"armGroupLabels":27,"otherNames":11},"balloon dilated","Through the expansion after the balloon is in place, improve the blood perfusion of nerve vessels to treat stenosis.",[15],{"type":29,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[31,34,36,38,40,42],{"name":32,"class":33},"Xuanwu Hospital, Beijing","OTHER",{"name":35,"class":33},"First Affiliated Hospital Xi'an Jiaotong University",{"name":37,"class":33},"First People's Hospital of Hangzhou",{"name":39,"class":33},"Jinan Central Hospital",{"name":41,"class":33},"The Affiliated Hospital of Qingdao University",{"name":43,"class":33},"Beijing Geriatric Hospital","100526884",false,"NCT06140550","Clinical Trial of Biolimus-coated Intracranial Balloon Dilation Catheter","Prospective, Multicenter, Randomized Controlled Clinical Trial to Evaluate the Effectiveness and Safety of Biolimus-coated Intracranial Balloon Dilation Catheter Treatment of Patients With Symptomatic Intracranial Atherosclerotic Stenosis","Inclusion Criteria:\n\n* 18 to 80 years old;\n* Symptomatic intracranial artery stenosis, and the degree of visual stenosis of target blood vessels under intracranial angiography is 70\\~99%(WASID method);\n\nExclusion Criteria:\n\n* Target blood vessels are seriously calcified and distorted, and it is difficult to put the interventional instruments in place or recover;\n* Ischemic cerebral infarction occurred 3 weeks before surgery;\n* Cerebral hemorrhage 3 months before operation;","ALL","18 Years","80 Years",{"count":54,"type":55},204,"ESTIMATED","INTERVENTIONAL",[58],"NA","This test took the target lesion restenosis rate 6 months after the operation as the main endpoint to verify the effectiveness of the intracranial balloon expansion catheter of Biolimus coating. After completing the follow-up 6 months after the operation, a clinical summary report was issued for the registration application of the product, and on this basis, 12 months of postoperative follow-up was carried out to evaluate the mid-term curative effect.",[61],"Intracranial Atherosclerotic Stenosis",[63,64],"Intracranial balloon","stenosis","NOT_YET_RECRUITING","2023-11-17",{"date":68,"type":69},"2023-11-20","ACTUAL",{"date":71,"type":55},"2023-11",{"date":73,"type":55},"2026-12",{"name":5,"class":6}]